TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Coagulation Factor Concentrates Market Research Report 2022

Global Coagulation Factor Concentrates Market Research Report 2022

  • Category:Life Sciences
  • Published on : 24 November 2022
  • Pages :94
  • Formats:
  • Report Code:SMR-7494612
OfferClick for best price

Best Price: $2320

Coagulation Factor Concentrates Market Size, Share 2022


Market Analysis and Insights: Global Coagulation Factor Concentrates Market

The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Coagulation Factor Concentrates market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Coagulation Factor Concentrates market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Coagulation Factor Concentrates market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Coagulation Factor Concentrates market.

Global Coagulation Factor Concentrates Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Factor VIII

Factor IX

Von Willebrand Factor

Prothrombin Complex Concentrates

Fibrinogen Concentrates

Factor XIII

Segment by Application

Neurology

Immunology

Hematology

Critical Care

Pulmonology

Hemato-Oncology

Rheumatology

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

By Company

CSL (Australia)

Grifols (Spain)

Shire (Ireland)

Octapharma (Switzerland)

Kedrion (Italy)

Bio Product Laboratory (UK)

Sanquin (Netherlands)

LFB (France)

Biotest (Germany)

Japan Blood Products Organization, China Biologic Products (China)

Green Cross Corporation (South Korea)

Shanghai RAAS Blood Products (China)

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Coagulation Factor Concentrates product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Coagulation Factor Concentrates, with price, sales, revenue, and global market share of Coagulation Factor Concentrates from 2019 to 2022.

Chapter 3, the Coagulation Factor Concentrates competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Coagulation Factor Concentrates breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Coagulation Factor Concentrates market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Coagulation Factor Concentrates.

Chapter 13, 14, and 15, to describe Coagulation Factor Concentrates sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Coagulation Factor Concentrates Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Coagulation Factor Concentrates Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 94 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Coagulation Factor Concentrates Market Overview
1.1 Product Overview and Scope of Coagulation Factor Concentrates
1.2 Coagulation Factor Concentrates Segment by Type
1.2.1 Global Coagulation Factor Concentrates Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Factor VIII
1.2.3 Factor IX
1.2.4 Von Willebrand Factor
1.2.5 Prothrombin Complex Concentrates
1.2.6 Fibrinogen Concentrates
1.2.7 Factor XIII
1.3 Coagulation Factor Concentrates Segment by Application
1.3.1 Global Coagulation Factor Concentrates Sales Comparison by Application: (2022-2028)
1.3.2 Neurology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Critical Care
1.3.6 Pulmonology
1.3.7 Hemato-Oncology
1.3.8 Rheumatology
1.3.9 Others
1.4 Global Coagulation Factor Concentrates Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor Concentrates Revenue 2017-2028
1.4.2 Global Coagulation Factor Concentrates Sales 2017-2028
1.4.3 Coagulation Factor Concentrates Market Size by Region: 2017 Versus 2021 Versus 2028
2 Coagulation Factor Concentrates Market Competition by Manufacturers
2.1 Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2017-2022)
2.2 Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Coagulation Factor Concentrates Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Coagulation Factor Concentrates Manufacturing Sites, Area Served, Product Type
2.5 Coagulation Factor Concentrates Market Competitive Situation and Trends
2.5.1 Coagulation Factor Concentrates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Coagulation Factor Concentrates Players Market Share by Revenue
2.5.3 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Factor Concentrates Retrospective Market Scenario by Region
3.1 Global Coagulation Factor Concentrates Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Coagulation Factor Concentrates Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Coagulation Factor Concentrates Market Facts & Figures by Country
3.3.1 North America Coagulation Factor Concentrates Sales by Country
3.3.2 North America Coagulation Factor Concentrates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Coagulation Factor Concentrates Market Facts & Figures by Country
3.4.1 Europe Coagulation Factor Concentrates Sales by Country
3.4.2 Europe Coagulation Factor Concentrates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Region
3.5.1 Asia Pacific Coagulation Factor Concentrates Sales by Region
3.5.2 Asia Pacific Coagulation Factor Concentrates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Coagulation Factor Concentrates Market Facts & Figures by Country
3.6.1 Latin America Coagulation Factor Concentrates Sales by Country
3.6.2 Latin America Coagulation Factor Concentrates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Country
3.7.1 Middle East and Africa Coagulation Factor Concentrates Sales by Country
3.7.2 Middle East and Africa Coagulation Factor Concentrates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Coagulation Factor Concentrates Historic Market Analysis by Type
4.1 Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
4.2 Global Coagulation Factor Concentrates Revenue Market Share by Type (2017-2022)
4.3 Global Coagulation Factor Concentrates Price by Type (2017-2022)
5 Global Coagulation Factor Concentrates Historic Market Analysis by Application
5.1 Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
5.2 Global Coagulation Factor Concentrates Revenue Market Share by Application (2017-2022)
5.3 Global Coagulation Factor Concentrates Price by Application (2017-2022)
6 Key Companies Profiled
6.1 CSL (Australia)
6.1.1 CSL (Australia) Corporation Information
6.1.2 CSL (Australia) Description and Business Overview
6.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.1.4 CSL (Australia) Coagulation Factor Concentrates Product Portfolio
6.1.5 CSL (Australia) Recent Developments/Updates
6.2 Grifols (Spain)
6.2.1 Grifols (Spain) Corporation Information
6.2.2 Grifols (Spain) Description and Business Overview
6.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Grifols (Spain) Coagulation Factor Concentrates Product Portfolio
6.2.5 Grifols (Spain) Recent Developments/Updates
6.3 Shire (Ireland)
6.3.1 Shire (Ireland) Corporation Information
6.3.2 Shire (Ireland) Description and Business Overview
6.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Shire (Ireland) Coagulation Factor Concentrates Product Portfolio
6.3.5 Shire (Ireland) Recent Developments/Updates
6.4 Octapharma (Switzerland)
6.4.1 Octapharma (Switzerland) Corporation Information
6.4.2 Octapharma (Switzerland) Description and Business Overview
6.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Octapharma (Switzerland) Coagulation Factor Concentrates Product Portfolio
6.4.5 Octapharma (Switzerland) Recent Developments/Updates
6.5 Kedrion (Italy)
6.5.1 Kedrion (Italy) Corporation Information
6.5.2 Kedrion (Italy) Description and Business Overview
6.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Kedrion (Italy) Coagulation Factor Concentrates Product Portfolio
6.5.5 Kedrion (Italy) Recent Developments/Updates
6.6 Bio Product Laboratory (UK)
6.6.1 Bio Product Laboratory (UK) Corporation Information
6.6.2 Bio Product Laboratory (UK) Description and Business Overview
6.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Portfolio
6.6.5 Bio Product Laboratory (UK) Recent Developments/Updates
6.7 Sanquin (Netherlands)
6.6.1 Sanquin (Netherlands) Corporation Information
6.6.2 Sanquin (Netherlands) Description and Business Overview
6.6.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sanquin (Netherlands) Coagulation Factor Concentrates Product Portfolio
6.7.5 Sanquin (Netherlands) Recent Developments/Updates
6.8 LFB (France)
6.8.1 LFB (France) Corporation Information
6.8.2 LFB (France) Description and Business Overview
6.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.8.4 LFB (France) Coagulation Factor Concentrates Product Portfolio
6.8.5 LFB (France) Recent Developments/Updates
6.9 Biotest (Germany)
6.9.1 Biotest (Germany) Corporation Information
6.9.2 Biotest (Germany) Description and Business Overview
6.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Biotest (Germany) Coagulation Factor Concentrates Product Portfolio
6.9.5 Biotest (Germany) Recent Developments/Updates
6.10 Japan Blood Products Organization, China Biologic Products (China)
6.10.1 Japan Blood Products Organization, China Biologic Products (China) Corporation Information
6.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
6.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Portfolio
6.10.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments/Updates
6.11 Green Cross Corporation (South Korea)
6.11.1 Green Cross Corporation (South Korea) Corporation Information
6.11.2 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Description and Business Overview
6.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Portfolio
6.11.5 Green Cross Corporation (South Korea) Recent Developments/Updates
6.12 Shanghai RAAS Blood Products (China)
6.12.1 Shanghai RAAS Blood Products (China) Corporation Information
6.12.2 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Description and Business Overview
6.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Portfolio
6.12.5 Shanghai RAAS Blood Products (China) Recent Developments/Updates
7 Coagulation Factor Concentrates Manufacturing Cost Analysis
7.1 Coagulation Factor Concentrates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Coagulation Factor Concentrates
7.4 Coagulation Factor Concentrates Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Coagulation Factor Concentrates Distributors List
8.3 Coagulation Factor Concentrates Customers
9 Coagulation Factor Concentrates Market Dynamics
9.1 Coagulation Factor Concentrates Industry Trends
9.2 Coagulation Factor Concentrates Market Drivers
9.3 Coagulation Factor Concentrates Market Challenges
9.4 Coagulation Factor Concentrates Market Restraints
10 Global Market Forecast
10.1 Coagulation Factor Concentrates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Coagulation Factor Concentrates by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Type (2023-2028)
10.2 Coagulation Factor Concentrates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Coagulation Factor Concentrates by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Application (2023-2028)
10.3 Coagulation Factor Concentrates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Coagulation Factor Concentrates by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Coagulation Factor Concentrates Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Coagulation Factor Concentrates Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Coagulation Factor Concentrates Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Coagulation Factor Concentrates Market Competitive Situation by Manufacturers in 2021
Table 5. Global Coagulation Factor Concentrates Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Coagulation Factor Concentrates Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Coagulation Factor Concentrates Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Coagulation Factor Concentrates Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Coagulation Factor Concentrates Manufacturing Sites and Area Served
Table 11. Manufacturers Coagulation Factor Concentrates Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor Concentrates as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Coagulation Factor Concentrates Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)
Table 17. Global Coagulation Factor Concentrates Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Coagulation Factor Concentrates Revenue Market Share by Region (2017-2022)
Table 19. North America Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 21. North America Coagulation Factor Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 23. Europe Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 25. Europe Coagulation Factor Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Coagulation Factor Concentrates Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Coagulation Factor Concentrates Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Coagulation Factor Concentrates Revenue Market Share by Region (2017-2022)
Table 31. Latin America Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 33. Latin America Coagulation Factor Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 39. Global Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 41. Global Coagulation Factor Concentrates Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Coagulation Factor Concentrates Revenue Share by Type (2017-2022)
Table 43. Global Coagulation Factor Concentrates Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Coagulation Factor Concentrates Sales (K Pcs) by Application (2017-2022)
Table 45. Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 46. Global Coagulation Factor Concentrates Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Coagulation Factor Concentrates Revenue Share by Application (2017-2022)
Table 48. Global Coagulation Factor Concentrates Price by Application (2017-2022) & (USD/Pcs)
Table 49. CSL (Australia) Corporation Information
Table 50. CSL (Australia) Description and Business Overview
Table 51. CSL (Australia) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. CSL (Australia) Coagulation Factor Concentrates Product
Table 53. CSL (Australia) Recent Developments/Updates
Table 54. Grifols (Spain) Corporation Information
Table 55. Grifols (Spain) Description and Business Overview
Table 56. Grifols (Spain) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Grifols (Spain) Coagulation Factor Concentrates Product
Table 58. Grifols (Spain) Recent Developments/Updates
Table 59. Shire (Ireland) Corporation Information
Table 60. Shire (Ireland) Description and Business Overview
Table 61. Shire (Ireland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Shire (Ireland) Coagulation Factor Concentrates Product
Table 63. Shire (Ireland) Recent Developments/Updates
Table 64. Octapharma (Switzerland) Corporation Information
Table 65. Octapharma (Switzerland) Description and Business Overview
Table 66. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Octapharma (Switzerland) Coagulation Factor Concentrates Product
Table 68. Octapharma (Switzerland) Recent Developments/Updates
Table 69. Kedrion (Italy) Corporation Information
Table 70. Kedrion (Italy) Description and Business Overview
Table 71. Kedrion (Italy) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Kedrion (Italy) Coagulation Factor Concentrates Product
Table 73. Kedrion (Italy) Recent Developments/Updates
Table 74. Bio Product Laboratory (UK) Corporation Information
Table 75. Bio Product Laboratory (UK) Description and Business Overview
Table 76. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product
Table 78. Bio Product Laboratory (UK) Recent Developments/Updates
Table 79. Sanquin (Netherlands) Corporation Information
Table 80. Sanquin (Netherlands) Description and Business Overview
Table 81. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. Sanquin (Netherlands) Coagulation Factor Concentrates Product
Table 83. Sanquin (Netherlands) Recent Developments/Updates
Table 84. LFB (France) Corporation Information
Table 85. LFB (France) Description and Business Overview
Table 86. LFB (France) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. LFB (France) Coagulation Factor Concentrates Product
Table 88. LFB (France) Recent Developments/Updates
Table 89. Biotest (Germany) Corporation Information
Table 90. Biotest (Germany) Description and Business Overview
Table 91. Biotest (Germany) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Biotest (Germany) Coagulation Factor Concentrates Product
Table 93. Biotest (Germany) Recent Developments/Updates
Table 94. Japan Blood Products Organization, China Biologic Products (China) Corporation Information
Table 95. Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
Table 96. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product
Table 98. Japan Blood Products Organization, China Biologic Products (China) Recent Developments/Updates
Table 99. Green Cross Corporation (South Korea) Corporation Information
Table 100. Green Cross Corporation (South Korea) Description and Business Overview
Table 101. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product
Table 103. Green Cross Corporation (South Korea) Recent Developments/Updates
Table 104. Shanghai RAAS Blood Products (China) Corporation Information
Table 105. Shanghai RAAS Blood Products (China) Description and Business Overview
Table 106. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product
Table 108. Shanghai RAAS Blood Products (China) Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Coagulation Factor Concentrates Distributors List
Table 112. Coagulation Factor Concentrates Customers List
Table 113. Coagulation Factor Concentrates Market Trends
Table 114. Coagulation Factor Concentrates Market Drivers
Table 115. Coagulation Factor Concentrates Market Challenges
Table 116. Coagulation Factor Concentrates Market Restraints
Table 117. Global Coagulation Factor Concentrates Sales Forecast by Type (2023-2028) & (K Pcs)
Table 118. Global Coagulation Factor Concentrates Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Coagulation Factor Concentrates Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Coagulation Factor Concentrates Sales Forecast by Application (2023-2028) & (K Pcs)
Table 122. Global Coagulation Factor Concentrates Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Coagulation Factor Concentrates Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Coagulation Factor Concentrates Sales Forecast by Region (2023-2028) & (K Pcs)
Table 126. Global Coagulation Factor Concentrates Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Coagulation Factor Concentrates Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Coagulation Factor Concentrates
Figure 2. Global Coagulation Factor Concentrates Market Share by Type in 2021 & 2028
Figure 3. Factor VIII Product Picture
Figure 4. Factor IX Product Picture
Figure 5. Von Willebrand Factor Product Picture
Figure 6. Prothrombin Complex Concentrates Product Picture
Figure 7. Fibrinogen Concentrates Product Picture
Figure 8. Factor XIII Product Picture
Figure 9. Global Coagulation Factor Concentrates Market Share by Application in 2021 & 2028
Figure 10. Neurology
Figure 11. Immunology
Figure 12. Hematology
Figure 13. Critical Care
Figure 14. Pulmonology
Figure 15. Hemato-Oncology
Figure 16. Rheumatology
Figure 17. Others
Figure 18. Global Coagulation Factor Concentrates Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Coagulation Factor Concentrates Market Size (2017-2028) & (US$ Million)
Figure 20. Global Coagulation Factor Concentrates Sales (2017-2028) & (K Pcs)
Figure 21. Coagulation Factor Concentrates Sales Share by Manufacturers in 2021
Figure 22. Global Coagulation Factor Concentrates Revenue Share by Manufacturers in 2021
Figure 23. The Global 5 and 10 Largest Coagulation Factor Concentrates Players: Market Share by Revenue in 2021
Figure 24. Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 25. Global Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)
Figure 26. Global Coagulation Factor Concentrates Sales Market Share by Region in 2021
Figure 27. Global Coagulation Factor Concentrates Revenue Market Share by Region (2017-2022)
Figure 28. Global Coagulation Factor Concentrates Revenue Market Share by Region in 2021
Figure 29. U.S. Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Canada Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Germany Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. France Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. U.K. Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Italy Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Russia Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. China Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Japan Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. South Korea Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. India Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Australia Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Taiwan Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Indonesia Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Thailand Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Malaysia Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Philippines Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Vietnam Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Mexico Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Brazil Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Argentina Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. Turkey Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 51. Saudi Arabia Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 52. UAE Coagulation Factor Concentrates Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 53. Sales Market Share of Coagulation Factor Concentrates by Type (2017-2022)
Figure 54. Manufacturing Cost Structure of Coagulation Factor Concentrates
Figure 55. Manufacturing Process Analysis of Coagulation Factor Concentrates
Figure 56. Coagulation Factor Concentrates Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount